Changchun BCHT Biotechnology Co (SHSE:688276) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Other Net Income (Loss)?

Changchun BCHT Biotechnology Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0 Mil.

Changchun BCHT Biotechnology Co's quarterly Other Net Income (Loss) declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥0 Mil) and declined from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥-0 Mil).

Changchun BCHT Biotechnology Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥-0 Mil) to Dec. 2022 (¥0 Mil) but then stayed the same from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).

Changchun BCHT Biotechnology Co Other Net Income (Loss) Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Other Net Income (Loss) Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Changchun BCHT Biotechnology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Changchun BCHT Biotechnology Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Changchun BCHT Biotechnology Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines